Mar 21, 2017 - Allergan plc (AGN) announced yesterday that the FDA has approved its Juvederm Vollure XC dermal filler for correction of facial wrinkles and folds in adults over the age of 21.
Mar 21, 2017 - Nektar Therapeutics??? (NKTR) shares surged 42.6% after the company announced positive results from a phase III efficacy study evaluating its investigational candidate, NKTR-181, in patients with moderate to severe chronic low back pain.
Mar 20, 2017 - London based AstraZeneca plc (AZN) received a second Complete Response Letter (CRL) from the FDA for its new drug application (NDA) for investigational drug ZS-9.
Mar 17, 2017 - Teva Pharmaceutical Industries Ltd. (TEVA) recently launched an authorized generic version of Allergan plc???s (AGN) oral contraceptive, Minastrin 24 Fe1, in the U.S.
Mar 10, 2017 - Welcome to your weekly digest of approaching regulatory and clinical readouts. Teva (NYSE:TEVA) expects a US decision on SD-809, its possible treatment for Huntington’s chorea, at the beginning of Apr
Feb 15, 2017 - Teva's joint venture with long-time Japanese OTC drug company Takeda began during 2016.The joint venture added $450M in generics revenue during the 4th Quarter of 2016.TEVA looks set to continue growi
Feb 15, 2017 - Teva's management fielded calls that put its dividend into question. Suggestions that company should split signals the stock's undervaluation. Teva's growth ahead in generics and specialty overlooked:
Feb 13, 2017 - Market futures are very positive this morning, and continue to climb 20 minutes before the opening bell sounds.
Aug 05, 2016 - Earlier last week, the Federal Trade Commission approved of Teva's acquisition of Allergan's generic pharma unit.Unsurprisingly, the +$40 Billion deal was closed this week.Teva's aggressive growth str
Aug 05, 2016 - Benchmarks ended mostly flat on Thursday as investors refrained from making big bets ahead of Friday’s U.S. nonfarm payroll report